DMAC earnings: a negative outcome, -9.1%

-9.1%DiaMedica Therapeutics Inc. (DMAC) →

On March 14, 2022, DiaMedica Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.1% in the window around the event. It had already run -13.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$2.54

1d before

$2.31

Event day

$2.30

1d after

$2.74

5d after

Pre-catalyst setup

-13.9%

30-day run-up

5023%

30-day volatility

0.3×

volume spike

DMAC catalyst calendar More earningss Prediction track record Full catalyst calendar